SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-095321
Filing Date
2022-04-05
Accepted
2022-04-04 19:18:05
Documents
17
Period of Report
2022-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d313223d8k.htm   iXBRL 8-K 33341
2 EX-10.1 d313223dex101.htm EX-10.1 27543
3 EX-10.2 d313223dex102.htm EX-10.2 11275
4 EX-99.1 d313223dex991.htm EX-99.1 58092
8 GRAPHIC g313223dsp001.jpg GRAPHIC 4231
9 GRAPHIC g313223g0405021300120.jpg GRAPHIC 8804
  Complete submission text file 0001193125-22-095321.txt   294262

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cbio-20220331.xsd EX-101.SCH 2892
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20220331_lab.xml EX-101.LAB 17994
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20220331_pre.xml EX-101.PRE 11285
11 EXTRACTED XBRL INSTANCE DOCUMENT d313223d8k_htm.xml XML 3335
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 22804648
SIC: 2834 Pharmaceutical Preparations